Large-scale testing (Phase 3)Active Not RecruitingNCT04436640
What this trial is testing
Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Who this might be right for
Axial SpondyloarthritisAnkylosing Spondylitisr-axSpa+1 more
UCB Biopharma SRL 508